HOME >> MEDICINE >> NEWS
9th European Congress on Lung Disease

The 9th annual meeting of the European Respiratory Society (ERS) will be held in Madrid, Spain, this fall. This is the leading gathering of respiratory specialists in Europe. Presentations will be given of the unpublished results of over 3000 studies covering the extremely broad-ranging field of respiratory and lung diseases.

Lung cancer, asthma, chronic bronchitis and sleep apnoea are just some of the topics that will be addressed at this annual Congress.

"It is one of the year's outstanding scientific events", says Nicols Gonzlez Mangado, the chairman of the congress. "This meeting will be a unique, historic occasion, as Spain will be welcoming over 10'000 of the world's leading specialists in respiratory pathology".

Over and above the 3000 advanced studies that have been selected for free communications (either oral presentations or posters), the program includes over 50 specialized symposia featuring the best experts, and covering a range from basic and applied research to still unpublished clinical trials.

"This meeting offers a very attractive combination for a wide audience of specialists, adds Manuel Cosio, the Vice-Chairman of the meeting. That is why the ERS has attracted more and more investigators from all over the world and why our annual meeting is really growing in importance. Madrid got a record number of submitted 3740 abstracts, out of which 3035 were accepted, Manuel Cosio is pleased to report.

One of the symposia, for instance, will be devoted to highly promising new approaches to the prevention of lung cancer. Very recent advances in this field have opened the way to pre-invasive cancer treatment, which stops the formation of cancer cells using an aerosol that will soon undergo human trials. Also in the field of lung cancer, the meeting will be told how it is becoming possible, using sophisticated medical imaging (computerized tomography) techniques, to diagnose the illness at a sufficiently early stage to apply therapy.
'"/>

Contact: Eric Schaerlig or Armelle Dulac
ERS99EK@cedos.int.ch
41-22-827-38-27
European Respiratory Society
7-Sep-1999


Page: 1 2 3

Related medicine news :

1. ESC releases the first European Guidelines on Percutaneous Coronary Interventions (PCI)
2. The European Society of Cardiology launches Women at Heart
3. Use of potentially inappropriate medications among elderly common in some European countries
4. European folic acid policies are not effective enough
5. New European cancer figures for 2004 major efforts needed against the big four killers
6. Third of European cancer patients use complementary and alternative therapies
7. A new service from the European Patent Office
8. European study highlights persistent 3 decade increase in childhood cancer incidence
9. European nations urged to ratify international treaty on tobacco control
10. Increased investment in radiotherapy will improve cure rates for European cancer patients
11. ESA looking for more European women to volunteer for WISE bed-rest study in Toulouse next year

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: European Congress Lung Disease

(Date:3/6/2015)... Follow us on LinkedIn – ... drug refers to testing of absorption, distribution, metabolism, and ... toxicity studies are clubbed together with ADME, it is ... on lowering costs and time during drug development are ... drug development model uses toxicity and efficacy testing in ...
(Date:3/6/2015)... USA (PRWEB) March 06, 2015 Parents ... the fatal reality of substance use disorders. School programs ... to be marginally successful. NOPE, or Narcotics Overdose Prevention ... nationwide, according to Healthline News on Feb. ... illicit and prescription opiate drugs, drug prevention proponents are ...
(Date:3/6/2015)... 06, 2015 Johnson & Johnson and ... on March 5, 2015 in Superior Court in the ... documents, a jury of 12 awarded Mrs. Perry $700,000 ... implanted with an Ethicon TVT Abbrevo plastic sling for ... three women also awarded $5 million in punitive damages. ...
(Date:3/6/2015)... DC (PRWEB) March 06, 2015 Magellan ... nation’s only comprehensive source for key trends and statistics ... spend, medical injectables. Executives from Magellan Rx Management will ... Trend Report: Discover Your Hidden Specialty Drug Spend,” a ... Information Services, Inc. , Specialty drug spend makes up ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
Breaking Medicine News(10 mins):Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5, 2015  IRIDEX Corporation (Nasdaq: IRIX ) ... ended January 3, 2015.  , Revenues were $11.8 ... the Company and up 11% from $10.6 million in the ... a record, up 12% from $38.3 million in 2013. ... up from 48.6% in the fourth quarter of the prior ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
Cached News: